These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 17114841)

  • 1. Refractory status epilepticus.
    Murthy JM
    Neurol India; 2006 Dec; 54(4):354-8. PubMed ID: 17114841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Status epilepticus: Refractory and super-refractory.
    Dubey D; Kalita J; Misra UK
    Neurol India; 2017; 65(Supplement):S12-S17. PubMed ID: 28281491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of burst suppression or coma using intravenous anesthetics in refractory status epilepticus.
    Kang BS; Jung KH; Shin JW; Moon JS; Byun JI; Lim JA; Moon HJ; Kim YS; Lee ST; Chu K; Lee SK
    J Clin Neurosci; 2015 May; 22(5):854-8. PubMed ID: 25744078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A one-year prospective study of refractory status epilepticus in Modena, Italy.
    Giovannini G; Monti G; Polisi MM; Mirandola L; Marudi A; Pinelli G; Valzania F; Girardis M; Nichelli PF; Meletti S
    Epilepsy Behav; 2015 Aug; 49():141-5. PubMed ID: 26074182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory status epilepticus: effect of treatment aggressiveness on prognosis.
    Rossetti AO; Logroscino G; Bromfield EB
    Arch Neurol; 2005 Nov; 62(11):1698-702. PubMed ID: 16286542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
    Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
    Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perampanel Treatment for Refractory Status Epilepticus in a Neurological Intensive Care Unit.
    Ho CJ; Lin CH; Lu YT; Shih FY; Hsu CW; Tsai WC; Tsai MH
    Neurocrit Care; 2019 Aug; 31(1):24-29. PubMed ID: 30891695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aborted and refractory status epilepticus in children: a comparative analysis.
    Lambrechtsen FA; Buchhalter JR
    Epilepsia; 2008 Apr; 49(4):615-25. PubMed ID: 18093148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.
    Claassen J; Hirsch LJ; Emerson RG; Mayer SA
    Epilepsia; 2002 Feb; 43(2):146-53. PubMed ID: 11903460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory generalised convulsive status epilepticus : a guide to treatment.
    Kälviäinen R; Eriksson K; Parviainen I
    CNS Drugs; 2005; 19(9):759-68. PubMed ID: 16142991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.
    Sutter R; Marsch S; Rüegg S
    CNS Drugs; 2013 Apr; 27(4):321-9. PubMed ID: 23533010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine continuous infusion for refractory status epilepticus in a patient with anticonvulsant hypersensitivity syndrome.
    Esaian D; Joset D; Lazarovits C; Dugan PC; Fridman D
    Ann Pharmacother; 2013 Nov; 47(11):1569-76. PubMed ID: 24259603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midazolam and pentobarbital for refractory status epilepticus.
    Holmes GL; Riviello JJ
    Pediatr Neurol; 1999 Apr; 20(4):259-64. PubMed ID: 10328273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory status epilepticus: a prospective observational study.
    Novy J; Logroscino G; Rossetti AO
    Epilepsia; 2010 Feb; 51(2):251-6. PubMed ID: 19817823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory status epilepticus.
    Fernandez A; Claassen J
    Curr Opin Crit Care; 2012 Apr; 18(2):127-31. PubMed ID: 22322261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very high dose phenobarbital for refractory status epilepticus.
    Tiamkao S; Mayurasakorn N; Suko P; Jitpimolmard S; Arunpongpaisal S; Phuttharak W; Auevitchayapat N; Vannaprasaht S; Tiamkao S; Phunikhom K; Chaiyakum A; Saengsuwan J
    J Med Assoc Thai; 2007 Dec; 90(12):2597-600. PubMed ID: 18386708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory and super-refractory status epilepticus in adults: a 9-year cohort study.
    Delaj L; Novy J; Ryvlin P; Marchi NA; Rossetti AO
    Acta Neurol Scand; 2017 Jan; 135(1):92-99. PubMed ID: 27080243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and treatment of refractory status epilepticus in the intensive care unit.
    Drislane FW; Lopez MR; Blum AS; Schomer DL
    J Clin Neurophysiol; 2008 Aug; 25(4):181-6. PubMed ID: 18677181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Risk Factors for Refractory Status Epilepticus.
    Tatro HA; Hamilton LA; Peters C; Rowe AS
    Ann Pharmacother; 2020 Jan; 54(1):14-21. PubMed ID: 31347376
    [No Abstract]   [Full Text] [Related]  

  • 20. Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study.
    Hottinger A; Sutter R; Marsch S; Rüegg S
    CNS Drugs; 2012 Sep; 26(9):761-72. PubMed ID: 22823481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.